We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

30 hedge funds and large institutions have $53.2M invested in Tempest Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

803% more capital invested

Capital invested by funds: $5.89M → $53.2M (+$47.3M)

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

14% less funds holding

Funds holding: 35 → 30 (-5)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

Holders
30
Holders Change
-5
Holders Change %
-14.29%
% of All Funds
0.67%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
11
Increased
6
Reduced
3
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$18.6M
2
FM
Frazier Management
Washington
+$14.7M
3
GPP
Great Point Partners
Connecticut
+$13.6M
4
ASP
Adams Street Partners
Illinois
+$4.85M
5
PM
Prosight Management
Texas
+$1.63M

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$401K
2
SM
Sabby Management
Florida
-$187K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$140K
4
BCM
Bridgeway Capital Management
Texas
-$109K
5
Northern Trust
Northern Trust
Illinois
-$49K
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
26
Elkfork Partners
Oregon
$2K -$2.06K -1 -50%
TAM
27
Tyers Asset Management
Texas
$2K +$2.06K +1 New
TCOV
28
Trust Company of Vermont
Vermont
$1K -$2.06K -1 Closed
Bank of America
29
Bank of America
North Carolina
$1K – – –
BWM
30
Baystate Wealth Management
Massachusetts
$1K – – –
Citigroup
31
Citigroup
New York
$1K – – –
Federated Hermes
32
Federated Hermes
Pennsylvania
$1K – – –
JP Morgan Chase
33
JP Morgan Chase
New York
$1K – – –
RE
34
RBC Europe
United Kingdom
$48 – – –
SM
35
Sabby Management
Florida
– -$187K -87 Closed
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
– -$140K -66 Closed
BCM
37
Bridgeway Capital Management
Texas
– -$109K -51 Closed
Northern Trust
38
Northern Trust
Illinois
– -$49K -23 Closed
HCM
39
Howland Capital Management
Massachusetts
– -$46K -21 Closed
California Public Employees Retirement System
40
California Public Employees Retirement System
California
– -$35K -16 Closed
OC
41
Oppenheimer & Co
New York
– -$26K -12 Closed
Two Sigma Investments
42
Two Sigma Investments
New York
– -$25K -12 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$23K -11 Closed
Two Sigma Advisers
44
Two Sigma Advisers
New York
– -$18K -9 Closed
PL
45
PWMCO LLC
Illinois
– -$12K -6 Closed
State Street
46
State Street
Massachusetts
– -$14K -6 Closed
Deutsche Bank
47
Deutsche Bank
Germany
– -$7K -3 Closed
Fidelity Investments
48
Fidelity Investments
Massachusetts
– -$1K -1 Closed
FCM
49
Flinton Capital Management
Pennsylvania
– -$2K -1 Closed
MAM
50
Meeder Asset Management
Ohio
– -$1K – –
1
2

TPST Hedge Fund Activity: Q4 2018 in Review

30 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2018, worth a combined $53.2M — up 803% from $5.89M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of TPST and 11 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 6 added.

The largest buyer was NEA Management Company, opening a new position worth an estimated $18.6M. The largest seller was Vanguard Group, cutting an estimated $401K.

  • 30 institutional investors held Tempest Therapeutics (TPST) as of Q4 2018, down from 35 in Q3 2018.
  • Funds reported $53.2M of Tempest Therapeutics stock for Q4 2018, up 803% quarter-over-quarter.
  • 11 funds opened new Tempest Therapeutics positions in Q4 2018 and 16 closed out, a net change of -5 holders.
  • The largest Tempest Therapeutics buyer in Q4 2018 was NEA Management Company, an estimated $18.6M added.
  • The largest Tempest Therapeutics seller in Q4 2018 was Vanguard Group, an estimated $401K sold.

Based on aggregated 13F filings for Q4 2018.